148 related articles for article (PubMed ID: 23311370)
21. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.
Sinek J; Frieboes H; Zheng X; Cristini V
Biomed Microdevices; 2004 Dec; 6(4):297-309. PubMed ID: 15548877
[TBL] [Abstract][Full Text] [Related]
22. Curative and palliative aspects of regional chemotherapy in combination with surgery.
Müller H; Hilger R
Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
[TBL] [Abstract][Full Text] [Related]
23. A mathematical model of the development of drug resistance to cancer chemotherapy.
Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329
[TBL] [Abstract][Full Text] [Related]
24. Measurement of delivery and metabolism of tirapazamine to tumour tissue using the multilayered cell culture model.
Kyle AH; Minchinton AI
Cancer Chemother Pharmacol; 1999; 43(3):213-20. PubMed ID: 9923551
[TBL] [Abstract][Full Text] [Related]
25. Cracking the mild, difficult and fiendish codes within and downstream of the EGFR to link diagnostics and therapeutics.
Waterfield M
Biochem Soc Trans; 2007 Feb; 35(Pt 1):1-6. PubMed ID: 17212578
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic drug monitoring in oncology: does it have a future?
McMahon G; O'Connor R
Bioanalysis; 2009 Jun; 1(3):507-11. PubMed ID: 21083145
[No Abstract] [Full Text] [Related]
27. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations.
de Pillis LG; Gu W; Radunskaya AE
J Theor Biol; 2006 Feb; 238(4):841-62. PubMed ID: 16153659
[TBL] [Abstract][Full Text] [Related]
28. Mathematical and numerical analysis for a model of growing metastatic tumors.
Barbolosi D; Benabdallah A; Hubert F; Verga F
Math Biosci; 2009 Mar; 218(1):1-14. PubMed ID: 19121638
[TBL] [Abstract][Full Text] [Related]
29. Personalized drug administration for cancer treatment using Model Reference Adaptive Control.
Babaei N; Salamci MU
J Theor Biol; 2015 Apr; 371():24-44. PubMed ID: 25665717
[TBL] [Abstract][Full Text] [Related]
30. Optimal drug regimens in cancer chemotherapy: a multi-objective approach.
Batmani Y; Khaloozadeh H
Comput Biol Med; 2013 Dec; 43(12):2089-95. PubMed ID: 24290925
[TBL] [Abstract][Full Text] [Related]
31. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy cancer treatment during the past sixty years].
Furue H
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1404-11. PubMed ID: 14584272
[TBL] [Abstract][Full Text] [Related]
33. Cancer: A medical emergency.
Harless W; Qiu Y
Med Hypotheses; 2006; 67(5):1054-9. PubMed ID: 16824693
[TBL] [Abstract][Full Text] [Related]
34. Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model.
Chen JH; Kuo YH; Luh HP
Math Biosci; 2013 Oct; 245(2):282-98. PubMed ID: 23927854
[TBL] [Abstract][Full Text] [Related]
35. Mathematical Analysis of a Mathematical Model of Chemovirotherapy: Effect of Drug Infusion Method.
Malinzi J
Comput Math Methods Med; 2019; 2019():7576591. PubMed ID: 30984283
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of neoadjuvant chemotherapy for the clinical utility of subsequently performed major cancer surgery.
Markman M
Curr Oncol Rep; 2008 Nov; 10(6):447-8. PubMed ID: 18928657
[No Abstract] [Full Text] [Related]
37. On optimal delivery of combination therapy for tumors.
d'Onofrio A; Ledzewicz U; Maurer H; Schättler H
Math Biosci; 2009 Nov; 222(1):13-26. PubMed ID: 19706298
[TBL] [Abstract][Full Text] [Related]
38. Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy.
McAneney H; O'Rourke SF
Phys Med Biol; 2007 Feb; 52(4):1039-54. PubMed ID: 17264369
[TBL] [Abstract][Full Text] [Related]
39. Evolving concepts in the systemic drug therapy of breast cancer.
Norton L
Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic Model for Cancer Growth and Response to Chemotherapy.
Simbawa E
Comput Math Methods Med; 2017; 2017():3676295. PubMed ID: 28928794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
